缺血预适应对接受侵入性操作者主要临床结局的影响:系统评价与荟萃分析
该系统评价与荟萃分析纳入85篇报告、89项随机对照比较,评估缺血预适应对接受侵入性操作者主要临床结局的影响。结果显示缺血预适应对全因死亡率无影响(68项比较,RR 0.96,95%CI 0.80–1.16,P=0.68,中等质量证据),不受临床场景或干预特征影响。可能降低卒中(18项试验,RR 0.72,95%CI 0.52–1.00,P=0.048,极低质量证据)和急性肾损伤(36项试验,RR 0.83,95%CI 0.71–0.97,P=0.02,低质量证据)发生率,但获益似乎仅限于非手术场景和轻度急性肾损伤。鉴于方法学问题和低事件率,不推荐常规采用缺血预适应。
要点
- 缺血预适应对全因死亡率无影响:68项比较、11619例、424例事件,RR 0.96(95%CI 0.80–1.16),中等质量证据。
- 可能降低卒中风险:18项试验、5995例、149例事件,RR 0.72(95%CI 0.52–1.00),极低质量证据。
- 可能降低急性肾损伤风险:36项试验、8493例、1443例事件,RR 0.83(95%CI 0.71–0.97),低质量证据。
- 急性肾损伤获益似乎仅限于非手术场景和轻度急性肾损伤。
- 不推荐常规使用缺血预适应,除非进一步高质量、足够把握度的证据显示获益。
适用人群与场景
- 接受侵入性操作的随机对照试验人群,涵盖各种临床场景(手术与非手术)。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入85篇报告、89项随机对照比较,中位样本量80例(四分位距60–149),中位干预时长1个月(范围1天–72个月)。
- 全因死亡率:68项比较、11619例、424例事件,RR 0.96(95%CI 0.80–1.16),P=0.68,中等质量证据;不受临床场景或干预特征影响。
- 卒中:18项试验、5995例、149例事件,RR 0.72(95%CI 0.52–1.00),P=0.048,极低质量证据。
- 急性肾损伤:36项试验、8493例、1443例事件,RR 0.83(95%CI 0.71–0.97),P=0.02,低质量证据;获益似乎仅限于非手术场景和轻度急性肾损伤。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入随机对照试验。
- 全因死亡率为中等质量证据;卒中为极低质量证据;急性肾损伤为低质量证据(GRADE评估)。
- 局限:可能的方法学问题及低事件率导致对卒中和急性肾损伤效应的不确定性。
对床旁实践的改变
- 不推荐常规使用缺血预适应,除非进一步高质量、足够把握度的证据显示获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To summarise the benefits and harms of ischaemic conditioning on major clinical outcomes in various settings.
DESIGN: Systematic review and meta-analysis.
DATA SOURCES: Medline, Embase, Cochrane databases, and International Clinical Trials Registry platform from inception through October 2015.
STUDY SELECTION: All randomised controlled comparisons of the effect of ischaemic conditioning on clinical outcomes were included.
DATA EXTRACTION: Two authors independently extracted data from individual reports. Reports of multiple intervention arms were treated as separate trials. Random effects models were used to calculate summary estimates for all cause mortality and other pre-specified clinical outcomes. All cause mortality and secondary outcomes with P<0.1 were examined for study quality by using the GRADE assessment tool, the effect of pre-specified characteristics by using meta-regression and Cochran C test, and trial sequential analysis by using the Copenhagen Trial Unit method.
RESULTS: 85 reports of 89 randomised comparisons were identified, with a median 80 (interquartile range 60-149) participants and median 1 (range 1 day-72 months) month intended duration. Ischaemic conditioning had no effect on all cause mortality (68 comparisons; 424 events; 11 619 participants; risk ratio 0.96, 95% confidence interval 0.80 to 1.16; P=0.68; moderate quality evidence) regardless of the clinical setting in which it was used or the particular intervention related characteristics. Ischaemic conditioning may reduce the rates of some secondary outcomes including stroke (18 trials; 5995 participants; 149 events; risk ratio 0.72, 0.52 to 1.00; P=0.048; very low quality evidence) and acute kidney injury (36 trials; 8493 participants; 1443 events; risk ratio 0.83, 0.71 to 0.97; P=0.02; low quality evidence), although the benefits seem to be confined to non-surgical settings and to mild episodes of acute kidney injury only.
CONCLUSIONS: Ischaemic conditioning has no overall effect on the risk of death. Possible effects on stroke and acute kidney injury are uncertain given methodological concerns and low event rates. Adoption of ischaemic conditioning cannot be recommended for routine use unless further high quality and well powered evidence shows benefit.
参考来源
- Sukkar L, Hong D, Wong MG, et al. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ. 2016. PMID: 27821641. doi:10.1136/bmj.i5599
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。